Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: moxa1 / Re: pappythom.... investigation
3
Sep 11, 2012 05:00PM
3
Sep 11, 2012 07:42PM
10
Sep 11, 2012 08:36PM
3
Sep 11, 2012 09:08PM
30
Sep 11, 2012 10:13PM
7
Sep 11, 2012 10:52PM
17
Sep 12, 2012 09:53AM
7
Sep 12, 2012 09:55AM
10
Sep 12, 2012 10:59AM
4
Sep 12, 2012 11:17AM

Full validation of the '336 has already been accomplished through the USPTO. Currently, the final Markman issues are being worked on by our legal team and will hopefully go in our favor as well, even while according to most here, and according to PTSC, what we already have in the Markman is a resounding win. PTSC/TPL have resolved their differences (supposedly). As PTSC states in their SEC filings, the company is totally reliant on revenue generated by Alliacense(TPL) through PDS in licensing the MMP. They have no ability to generate any real revenue otherwise. So basically, our BOD and Management have set up a situation whereby PTSC and themselves are bystanders to a process that will run its course and succeed or fail INDEPENDENTLY of anything they do at this point.

You and others are touting the ITC and T3 process being on the verge of a huge victory. I should remind you that over the last 5 years, many posters have at varying times condemned those who would act to right the wrongs based on this same argument. Yet as we all know, the goal posts were always moved when it didn't come to fruition as they had hoped.

Considering this corporate structure and strategy, and your argument that the MMP is on the precipice of monumental success, it seems the ONLY thing that would preclude that success from occuring is a defeat at the ITC or in the T3 case. Furthermore, assuming the success as you are, the only thing that would prevent the resultant windfall from making it to the PTSC shareholder would be the dissolution of PTSC itself or perhaps a committment from the BOD to find other ways of investing/spending the money than dividend distributions, something which by they way THIS management and BOD has a history of doing.

Exactly how does an SEC investigation impair the ITC or T3 process, or even the licensing process for that matter? If anything, it serves to either correct injustices that may have occurred or are occuring, cause the company to redouble its efforts to be squeaky clean (as it once boasted it was) due to the process, or perhaps will do nothing.

None of those affect the licensing or litigation process do they? None of those would affect the long term pps prospects of PTSC, except to perhaps enhance them in the event of positive developments at the T3 & ITC venues. Seems to me the only thing that might be affected is the short term pps in the even an SEC investigation became public, and frankly, knowing what we as shareholders do know about the history of the company, that would most likely HELP the pps if that occurred as it would lend an air of transparency and regulatory protection to shareholders were the perception of none exists currently.

You seem mainly concerned over the short term pps fluctuations. Why is that?

Share
New Message
Please login to post a reply